nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrosine—L-Tyrosine—Melphalan—ovarian cancer	0.426	0.5	CrCrCtD
Metyrosine—Ibuprofen—Melphalan—ovarian cancer	0.426	0.5	CrCrCtD
Metyrosine—TH—Dopaminergic Neurogenesis—LMX1A—ovarian cancer	0.0172	0.167	CbGpPWpGaD
Metyrosine—TH—Alpha-synuclein signaling—KLK6—ovarian cancer	0.0167	0.162	CbGpPWpGaD
Metyrosine—TH—Amine-derived hormones—SLC5A5—ovarian cancer	0.00596	0.0578	CbGpPWpGaD
Metyrosine—TH—Monoamine Transport—RBL2—ovarian cancer	0.00584	0.0567	CbGpPWpGaD
Metyrosine—TH—Dopamine metabolism—SOD1—ovarian cancer	0.0058	0.0563	CbGpPWpGaD
Metyrosine—TH—Monoamine Transport—PVRL2—ovarian cancer	0.00531	0.0515	CbGpPWpGaD
Metyrosine—TH—Alpha-synuclein signaling—PARK2—ovarian cancer	0.00465	0.0451	CbGpPWpGaD
Metyrosine—TH—Parkinsons Disease Pathway—PARK2—ovarian cancer	0.00395	0.0383	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—ATF3—ovarian cancer	0.00265	0.0258	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—ATF3—ovarian cancer	0.00231	0.0225	CbGpPWpGaD
Metyrosine—TH—Parkinsons Disease Pathway—CCNE1—ovarian cancer	0.00227	0.0221	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—GADD45A—ovarian cancer	0.00213	0.0207	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—BRCA1—ovarian cancer	0.00183	0.0177	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—TOP1—ovarian cancer	0.00167	0.0162	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—PPP1CC—ovarian cancer	0.00146	0.0142	CbGpPWpGaD
Metyrosine—Anaemia—Altretamine—ovarian cancer	0.00145	0.0337	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—HNF1B—ovarian cancer	0.00127	0.0123	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Altretamine—ovarian cancer	0.00125	0.0292	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—ESR1—ovarian cancer	0.00122	0.0118	CbGpPWpGaD
Metyrosine—TH—Dopaminergic Neurogenesis—STAT3—ovarian cancer	0.00117	0.0114	CbGpPWpGaD
Metyrosine—TH—Parkinsons Disease Pathway—CASP3—ovarian cancer	0.00115	0.0112	CbGpPWpGaD
Metyrosine—Fatigue—Altretamine—ovarian cancer	0.0011	0.0257	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—ESR1—ovarian cancer	0.00106	0.0103	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—MMP2—ovarian cancer	0.00102	0.00991	CbGpPWpGaD
Metyrosine—Asthenia—Altretamine—ovarian cancer	0.000919	0.0214	CcSEcCtD
Metyrosine—Ibuprofen—CXCL8—ovarian cancer	0.000892	0.6	CrCbGaD
Metyrosine—TH—ATF-2 transcription factor network—CXCL8—ovarian cancer	0.000849	0.00824	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—SLC5A5—ovarian cancer	0.00083	0.00805	CbGpPWpGaD
Metyrosine—Vomiting—Altretamine—ovarian cancer	0.000814	0.0189	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—CCND1—ovarian cancer	0.000791	0.00768	CbGpPWpGaD
Metyrosine—Blood disorder—Paclitaxel—ovarian cancer	0.000782	0.0182	CcSEcCtD
Metyrosine—Nausea—Altretamine—ovarian cancer	0.000761	0.0177	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Topotecan—ovarian cancer	0.000742	0.0173	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CXCL8—ovarian cancer	0.00074	0.00719	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—CDKN1B—ovarian cancer	0.000723	0.00702	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—IL2—ovarian cancer	0.000707	0.00687	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—CCND1—ovarian cancer	0.00069	0.00669	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—CTNNB1—ovarian cancer	0.000683	0.00663	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—MMP9—ovarian cancer	0.000669	0.0065	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—PTEN—ovarian cancer	0.000666	0.00646	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—MAPK3—ovarian cancer	0.000652	0.00633	CbGpPWpGaD
Metyrosine—Hallucination—Chlorambucil—ovarian cancer	0.000637	0.0148	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Vinorelbine—ovarian cancer	0.000635	0.0148	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—MAPK1—ovarian cancer	0.00062	0.00602	CbGpPWpGaD
Metyrosine—Thrombocytosis—Epirubicin—ovarian cancer	0.000601	0.014	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—TYMS—ovarian cancer	0.000589	0.00572	CbGpPWpGaD
Metyrosine—Thrombocytosis—Doxorubicin—ovarian cancer	0.000556	0.0129	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—MYC—ovarian cancer	0.000553	0.00537	CbGpPWpGaD
Metyrosine—Swelling—Paclitaxel—ovarian cancer	0.000538	0.0125	CcSEcCtD
Metyrosine—Tremor—Chlorambucil—ovarian cancer	0.000523	0.0122	CcSEcCtD
Metyrosine—Nasal congestion—Paclitaxel—ovarian cancer	0.000521	0.0121	CcSEcCtD
Metyrosine—Anaemia—Chlorambucil—ovarian cancer	0.000515	0.012	CcSEcCtD
Metyrosine—TH—Metabolism—NME2—ovarian cancer	0.000503	0.00488	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—IL6—ovarian cancer	0.000477	0.00463	CbGpPWpGaD
Metyrosine—Confusional state—Chlorambucil—ovarian cancer	0.000459	0.0107	CcSEcCtD
Metyrosine—Anaemia—Topotecan—ovarian cancer	0.000459	0.0107	CcSEcCtD
Metyrosine—Swelling—Docetaxel—ovarian cancer	0.000456	0.0106	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—TP53—ovarian cancer	0.000454	0.00441	CbGpPWpGaD
Metyrosine—Anaemia—Melphalan—ovarian cancer	0.000449	0.0104	CcSEcCtD
Metyrosine—Blood disorder—Epirubicin—ovarian cancer	0.000447	0.0104	CcSEcCtD
Metyrosine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.000446	0.0104	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.000427	0.00993	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—IL6—ovarian cancer	0.000416	0.00404	CbGpPWpGaD
Metyrosine—Blood disorder—Doxorubicin—ovarian cancer	0.000414	0.00962	CcSEcCtD
Metyrosine—Thrombocytopenia—Topotecan—ovarian cancer	0.000397	0.00923	CcSEcCtD
Metyrosine—Anaemia—Vinorelbine—ovarian cancer	0.000393	0.00913	CcSEcCtD
Metyrosine—Fatigue—Chlorambucil—ovarian cancer	0.000392	0.00913	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.00039	0.00378	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Melphalan—ovarian cancer	0.000388	0.00903	CcSEcCtD
Metyrosine—Dysuria—Paclitaxel—ovarian cancer	0.000383	0.00892	CcSEcCtD
Metyrosine—Feeling abnormal—Chlorambucil—ovarian cancer	0.000375	0.00872	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000373	0.00362	CbGpPWpGaD
Metyrosine—Acetaminophen—ABCB1—ovarian cancer	0.000372	0.251	CrCbGaD
Metyrosine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000372	0.00866	CcSEcCtD
Metyrosine—Salivary hypersecretion—Epirubicin—ovarian cancer	0.000363	0.00844	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.000362	0.00842	CcSEcCtD
Metyrosine—Urticaria—Chlorambucil—ovarian cancer	0.000362	0.00841	CcSEcCtD
Metyrosine—Abdominal pain—Chlorambucil—ovarian cancer	0.00036	0.00837	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.00036	0.00349	CbGpPWpGaD
Metyrosine—Fatigue—Topotecan—ovarian cancer	0.000349	0.00812	CcSEcCtD
Metyrosine—Haematuria—Paclitaxel—ovarian cancer	0.000349	0.00811	CcSEcCtD
Metyrosine—Fatigue—Melphalan—ovarian cancer	0.000342	0.00795	CcSEcCtD
Metyrosine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000339	0.00789	CcSEcCtD
Metyrosine—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.000336	0.00781	CcSEcCtD
Metyrosine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000335	0.0078	CcSEcCtD
Metyrosine—Feeling abnormal—Topotecan—ovarian cancer	0.000334	0.00776	CcSEcCtD
Metyrosine—Gastrointestinal pain—Topotecan—ovarian cancer	0.000331	0.00771	CcSEcCtD
Metyrosine—Asthenia—Chlorambucil—ovarian cancer	0.000327	0.00759	CcSEcCtD
Metyrosine—TH—Metabolism—CYTB—ovarian cancer	0.000324	0.00315	CbGpPWpGaD
Metyrosine—Oedema peripheral—Paclitaxel—ovarian cancer	0.000323	0.00752	CcSEcCtD
Metyrosine—Urticaria—Topotecan—ovarian cancer	0.000322	0.00749	CcSEcCtD
Metyrosine—Abdominal pain—Topotecan—ovarian cancer	0.00032	0.00745	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000317	0.00307	CbGpPWpGaD
Metyrosine—Urticaria—Melphalan—ovarian cancer	0.000315	0.00733	CcSEcCtD
Metyrosine—Diarrhoea—Chlorambucil—ovarian cancer	0.000311	0.00724	CcSEcCtD
Metyrosine—Fatigue—Vinorelbine—ovarian cancer	0.000299	0.00695	CcSEcCtD
Metyrosine—Hypersensitivity—Topotecan—ovarian cancer	0.000299	0.00694	CcSEcCtD
Metyrosine—Hypersensitivity—Melphalan—ovarian cancer	0.000292	0.0068	CcSEcCtD
Metyrosine—Asthenia—Topotecan—ovarian cancer	0.000291	0.00676	CcSEcCtD
Metyrosine—Vomiting—Chlorambucil—ovarian cancer	0.000289	0.00673	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—PTEN—ovarian cancer	0.000286	0.00278	CbGpPWpGaD
Metyrosine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000286	0.00664	CcSEcCtD
Metyrosine—Asthenia—Melphalan—ovarian cancer	0.000285	0.00662	CcSEcCtD
Metyrosine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000283	0.00659	CcSEcCtD
Metyrosine—TH—Metabolism—BRIP1—ovarian cancer	0.000283	0.00275	CbGpPWpGaD
Metyrosine—TH—Metabolism—PPP1CC—ovarian cancer	0.000283	0.00275	CbGpPWpGaD
Metyrosine—Diarrhoea—Topotecan—ovarian cancer	0.000277	0.00645	CcSEcCtD
Metyrosine—Urticaria—Vinorelbine—ovarian cancer	0.000275	0.0064	CcSEcCtD
Metyrosine—Abdominal pain—Vinorelbine—ovarian cancer	0.000274	0.00637	CcSEcCtD
Metyrosine—Oedema peripheral—Docetaxel—ovarian cancer	0.000274	0.00637	CcSEcCtD
Metyrosine—Diarrhoea—Melphalan—ovarian cancer	0.000271	0.00631	CcSEcCtD
Metyrosine—Nausea—Chlorambucil—ovarian cancer	0.00027	0.00629	CcSEcCtD
Metyrosine—Tremor—Paclitaxel—ovarian cancer	0.000268	0.00622	CcSEcCtD
Metyrosine—Anaemia—Paclitaxel—ovarian cancer	0.000264	0.00614	CcSEcCtD
Metyrosine—Vomiting—Topotecan—ovarian cancer	0.000258	0.00599	CcSEcCtD
Metyrosine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000255	0.00594	CcSEcCtD
Metyrosine—Headache—Topotecan—ovarian cancer	0.000254	0.0059	CcSEcCtD
Metyrosine—Vomiting—Melphalan—ovarian cancer	0.000252	0.00587	CcSEcCtD
Metyrosine—Asthenia—Vinorelbine—ovarian cancer	0.000249	0.00578	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000244	0.00568	CcSEcCtD
Metyrosine—Anxiety—Paclitaxel—ovarian cancer	0.000242	0.00564	CcSEcCtD
Metyrosine—Nausea—Topotecan—ovarian cancer	0.000241	0.0056	CcSEcCtD
Metyrosine—Dry mouth—Paclitaxel—ovarian cancer	0.000238	0.00553	CcSEcCtD
Metyrosine—Diarrhoea—Vinorelbine—ovarian cancer	0.000237	0.00552	CcSEcCtD
Metyrosine—Nausea—Melphalan—ovarian cancer	0.000236	0.00548	CcSEcCtD
Metyrosine—Confusional state—Paclitaxel—ovarian cancer	0.000235	0.00547	CcSEcCtD
Metyrosine—Eosinophilia—Epirubicin—ovarian cancer	0.000232	0.0054	CcSEcCtD
Metyrosine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000228	0.00531	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000226	0.00525	CcSEcCtD
Metyrosine—Anaemia—Docetaxel—ovarian cancer	0.000224	0.0052	CcSEcCtD
Metyrosine—Ibuprofen—ABCB1—ovarian cancer	0.000221	0.149	CrCbGaD
Metyrosine—Vomiting—Vinorelbine—ovarian cancer	0.00022	0.00513	CcSEcCtD
Metyrosine—Dysuria—Epirubicin—ovarian cancer	0.000219	0.0051	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000219	0.00213	CbGpPWpGaD
Metyrosine—Headache—Vinorelbine—ovarian cancer	0.000217	0.00505	CcSEcCtD
Metyrosine—Eosinophilia—Doxorubicin—ovarian cancer	0.000215	0.00499	CcSEcCtD
Metyrosine—Insomnia—Paclitaxel—ovarian cancer	0.000211	0.0049	CcSEcCtD
Metyrosine—Nausea—Vinorelbine—ovarian cancer	0.000206	0.00479	CcSEcCtD
Metyrosine—Dysuria—Doxorubicin—ovarian cancer	0.000203	0.00472	CcSEcCtD
Metyrosine—Dry mouth—Docetaxel—ovarian cancer	0.000202	0.00469	CcSEcCtD
Metyrosine—Fatigue—Paclitaxel—ovarian cancer	0.000201	0.00467	CcSEcCtD
Metyrosine—Haematuria—Epirubicin—ovarian cancer	0.000199	0.00463	CcSEcCtD
Metyrosine—Confusional state—Docetaxel—ovarian cancer	0.000199	0.00463	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—TP53—ovarian cancer	0.000195	0.0019	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000193	0.0045	CcSEcCtD
Metyrosine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000192	0.00447	CcSEcCtD
Metyrosine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000191	0.00443	CcSEcCtD
Metyrosine—TH—Metabolism—YAP1—ovarian cancer	0.00019	0.00184	CbGpPWpGaD
Metyrosine—Urticaria—Paclitaxel—ovarian cancer	0.000185	0.00431	CcSEcCtD
Metyrosine—Oedema peripheral—Epirubicin—ovarian cancer	0.000185	0.0043	CcSEcCtD
Metyrosine—Haematuria—Doxorubicin—ovarian cancer	0.000184	0.00429	CcSEcCtD
Metyrosine—Abdominal pain—Paclitaxel—ovarian cancer	0.000184	0.00429	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—IL6—ovarian cancer	0.000179	0.00174	CbGpPWpGaD
Metyrosine—Insomnia—Docetaxel—ovarian cancer	0.000179	0.00416	CcSEcCtD
Metyrosine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000172	0.00399	CcSEcCtD
Metyrosine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000171	0.00398	CcSEcCtD
Metyrosine—Fatigue—Docetaxel—ovarian cancer	0.00017	0.00396	CcSEcCtD
Metyrosine—Asthenia—Paclitaxel—ovarian cancer	0.000167	0.00389	CcSEcCtD
Metyrosine—Feeling abnormal—Docetaxel—ovarian cancer	0.000163	0.00379	CcSEcCtD
Metyrosine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000162	0.00376	CcSEcCtD
Metyrosine—Diarrhoea—Paclitaxel—ovarian cancer	0.00016	0.00371	CcSEcCtD
Metyrosine—Abdominal pain—Docetaxel—ovarian cancer	0.000156	0.00363	CcSEcCtD
Metyrosine—TH—Metabolism—FASN—ovarian cancer	0.000155	0.0015	CbGpPWpGaD
Metyrosine—TH—Metabolism—SLC5A5—ovarian cancer	0.000152	0.00148	CbGpPWpGaD
Metyrosine—Anaemia—Epirubicin—ovarian cancer	0.000151	0.00351	CcSEcCtD
Metyrosine—Vomiting—Paclitaxel—ovarian cancer	0.000148	0.00345	CcSEcCtD
Metyrosine—TH—Metabolism—SLC2A1—ovarian cancer	0.000147	0.00143	CbGpPWpGaD
Metyrosine—Headache—Paclitaxel—ovarian cancer	0.000146	0.0034	CcSEcCtD
Metyrosine—Hypersensitivity—Docetaxel—ovarian cancer	0.000146	0.00339	CcSEcCtD
Metyrosine—Asthenia—Docetaxel—ovarian cancer	0.000142	0.0033	CcSEcCtD
Metyrosine—TH—Metabolism—CYP1B1—ovarian cancer	0.000141	0.00137	CbGpPWpGaD
Metyrosine—Anaemia—Doxorubicin—ovarian cancer	0.00014	0.00325	CcSEcCtD
Metyrosine—Anxiety—Epirubicin—ovarian cancer	0.000139	0.00322	CcSEcCtD
Metyrosine—Nausea—Paclitaxel—ovarian cancer	0.000138	0.00322	CcSEcCtD
Metyrosine—Dry mouth—Epirubicin—ovarian cancer	0.000136	0.00316	CcSEcCtD
Metyrosine—Diarrhoea—Docetaxel—ovarian cancer	0.000135	0.00314	CcSEcCtD
Metyrosine—Confusional state—Epirubicin—ovarian cancer	0.000134	0.00313	CcSEcCtD
Metyrosine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000131	0.00303	CcSEcCtD
Metyrosine—Anxiety—Doxorubicin—ovarian cancer	0.000128	0.00298	CcSEcCtD
Metyrosine—Dry mouth—Doxorubicin—ovarian cancer	0.000126	0.00293	CcSEcCtD
Metyrosine—Vomiting—Docetaxel—ovarian cancer	0.000126	0.00292	CcSEcCtD
Metyrosine—TH—Metabolism—PPP2R1A—ovarian cancer	0.000125	0.00121	CbGpPWpGaD
Metyrosine—Confusional state—Doxorubicin—ovarian cancer	0.000124	0.00289	CcSEcCtD
Metyrosine—Headache—Docetaxel—ovarian cancer	0.000124	0.00288	CcSEcCtD
Metyrosine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000121	0.00281	CcSEcCtD
Metyrosine—Insomnia—Epirubicin—ovarian cancer	0.000121	0.0028	CcSEcCtD
Metyrosine—Nausea—Docetaxel—ovarian cancer	0.000117	0.00273	CcSEcCtD
Metyrosine—TH—Metabolism—ABCB1—ovarian cancer	0.000116	0.00113	CbGpPWpGaD
Metyrosine—Fatigue—Epirubicin—ovarian cancer	0.000115	0.00267	CcSEcCtD
Metyrosine—TH—Metabolism—TYMS—ovarian cancer	0.000114	0.00111	CbGpPWpGaD
Metyrosine—Insomnia—Doxorubicin—ovarian cancer	0.000112	0.00259	CcSEcCtD
Metyrosine—Feeling abnormal—Epirubicin—ovarian cancer	0.00011	0.00255	CcSEcCtD
Metyrosine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000109	0.00253	CcSEcCtD
Metyrosine—Fatigue—Doxorubicin—ovarian cancer	0.000106	0.00247	CcSEcCtD
Metyrosine—Urticaria—Epirubicin—ovarian cancer	0.000106	0.00246	CcSEcCtD
Metyrosine—Abdominal pain—Epirubicin—ovarian cancer	0.000105	0.00245	CcSEcCtD
Metyrosine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000102	0.00236	CcSEcCtD
Metyrosine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000101	0.00235	CcSEcCtD
Metyrosine—Hypersensitivity—Epirubicin—ovarian cancer	9.82e-05	0.00228	CcSEcCtD
Metyrosine—Urticaria—Doxorubicin—ovarian cancer	9.8e-05	0.00228	CcSEcCtD
Metyrosine—Abdominal pain—Doxorubicin—ovarian cancer	9.75e-05	0.00227	CcSEcCtD
Metyrosine—Asthenia—Epirubicin—ovarian cancer	9.56e-05	0.00222	CcSEcCtD
Metyrosine—TH—Metabolism—CAV1—ovarian cancer	9.19e-05	0.000893	CbGpPWpGaD
Metyrosine—Diarrhoea—Epirubicin—ovarian cancer	9.12e-05	0.00212	CcSEcCtD
Metyrosine—Hypersensitivity—Doxorubicin—ovarian cancer	9.09e-05	0.00211	CcSEcCtD
Metyrosine—Asthenia—Doxorubicin—ovarian cancer	8.85e-05	0.00206	CcSEcCtD
Metyrosine—Vomiting—Epirubicin—ovarian cancer	8.47e-05	0.00197	CcSEcCtD
Metyrosine—Diarrhoea—Doxorubicin—ovarian cancer	8.44e-05	0.00196	CcSEcCtD
Metyrosine—TH—Metabolism—PIK3CG—ovarian cancer	8.37e-05	0.000813	CbGpPWpGaD
Metyrosine—Headache—Epirubicin—ovarian cancer	8.35e-05	0.00194	CcSEcCtD
Metyrosine—Nausea—Epirubicin—ovarian cancer	7.92e-05	0.00184	CcSEcCtD
Metyrosine—Vomiting—Doxorubicin—ovarian cancer	7.84e-05	0.00182	CcSEcCtD
Metyrosine—Headache—Doxorubicin—ovarian cancer	7.73e-05	0.0018	CcSEcCtD
Metyrosine—TH—Metabolism—PIK3CD—ovarian cancer	7.36e-05	0.000715	CbGpPWpGaD
Metyrosine—Nausea—Doxorubicin—ovarian cancer	7.33e-05	0.0017	CcSEcCtD
Metyrosine—TH—Metabolism—PIK3CB—ovarian cancer	6.42e-05	0.000623	CbGpPWpGaD
Metyrosine—TH—Metabolism—PTEN—ovarian cancer	5.54e-05	0.000538	CbGpPWpGaD
Metyrosine—TH—Metabolism—PIK3CA—ovarian cancer	3.91e-05	0.00038	CbGpPWpGaD
Metyrosine—TH—Metabolism—AKT1—ovarian cancer	3.2e-05	0.00031	CbGpPWpGaD
